Clinical Trials Directory

Trials / Completed

CompletedNCT02593344

Peripheral Endothelial Function in Asthmatic Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to assess the peripheral endothelial function in adult asthmatic patients and the relationship between the peripheral endothelial function and the pulmonary function.

Detailed description

The primary criteria is the peripheral endothelial function that will be assessed by the measure of flow-mediated dilation (reactive hyperemia-peripheral artery tone index). The pulmonary function will be assessed by the measures of the FEV1, the forced vital capacity (FVC) and the expiratory flow between 25% and 75% (FEF25-75%). The relationship between these parameters of the pulmonary function and the peripheral endothelial function will be analyzed. In addition, a relationship between peripheral endothelial function and the level of asthma control (Asthma Control Test (ACT)), the cardiovascular risk factors (SCORE INdex) and the treatment for asthma (controllers) will be also assessed.

Conditions

Interventions

TypeNameDescription
DEVICEEndopatmeasure of peripheral endothelial function by the reactive hyperemia-peripheral artery tone index with a specific device (Endopat)

Timeline

Start date
2012-12-13
Primary completion
2015-04-09
Completion
2015-04-09
First posted
2015-11-02
Last updated
2018-10-03

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02593344. Inclusion in this directory is not an endorsement.